课题基金 / 基金详情

项目摘要

项目成果

DAVID NEMAZEE的其他基金

相似基金

相关文献

中文摘要
翻译
本文为研究磷脂酶D3 (Phospholipase D3, PLD3)的功能及其对糖尿病的治疗作用的一项R01建议
英文摘要
This is a R01 proposal to study the function of Phospholipase D3 (PLD3) and its contribution to neurodegeneration in mouse models. PLD3 missense mutations and under expression have been implicated in Alzheimer's disease (AD) and in Spinocerebellar Ataxia, but the mechanisms by which these mutations alter function are unclear. PLD3 protein is associated with neuritic AD plaques and has been implicated in Ab and Tau processing. We have recently discovered that PLD3 and a related protein PLD4 are not phospholipases, as was thought, but are in fact single- stranded DNA and RNA exonucleases localized in endolysosomes. PLD3 and PLD4 can strongly influence nucleic acid recognition by toll-like receptors (TLR) 7,8 and 9. Mice lacking both PLD3 and PLD4 enzymes die of massive autoinflammation, whereas the phenotype of Pld3–/– mice is relatively subtle and has not been investigated in older mice. Here we propose to study the roles of PLD3 in more detail by evaluating functional alterations of disease associated PLD3 alleles and by generating tools to assess the effects of deficiency of PLD3 and PLD4 in microglia and other tissues of the brain.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Role of PLD3 in nucleic acid recognition and brain function
  • 批准号:
    10525053
  • 项目类别:
  • 资助金额:
    $133.13万
  • 财政年份:
    2022
  • 负责人:
    DAVID NEMAZEE
  • 依托单位:
Immune Tolerance in Non-Clonal Immune Systems
  • 批准号:
    9546043
  • 项目类别:
  • 资助金额:
    $53.47万
  • 财政年份:
    2019
  • 负责人:
    DAVID NEMAZEE
  • 依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
  • 批准号:
    10190786
  • 项目类别:
  • 资助金额:
    $67.91万
  • 财政年份:
    2019
  • 负责人:
    DAVID NEMAZEE
  • 依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
  • 批准号:
    10436822
  • 项目类别:
  • 资助金额:
    $67.91万
  • 财政年份:
    2019
  • 负责人:
    DAVID NEMAZEE
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: